MannKind inks royalty purchase agreement for up to $200M
Westlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →
Cottage, independent physicians partner to open new surgery center
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CenCal Health celebrates 40th anniversary
CenCal Health celebrated its 40th anniversary at a Dec. 6 program at the Hilton Santa Barbara Beach Front Resort. “CenCal Health is grateful for the partnership of local healthcare providers and county agencies,” Marina Owen, the organization’s CEO, said. “Over four decades ago, this community had the foresight to come together and organize to more effectively Read More →
A psychedelic renaissance: Lucid Therapeutics aims to heal mental wounds
For nearly two decades, Dr. Remi Drozd spent his life healing people’s physical pain as an emergency room physician on the East Coast. And while it brought him joy, it also left him thinking about the subsect of people he felt he couldn’t help quite as easily. “For 15 years I witnessed people going through Read More →
Sutter Health sees expenses rise in the third quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Acelyrin shares decline after programming error disclosure
Conejo Valley-based Acelyrin saw shares plummet more than 30% on Nov. 28 after the biotechnology startup announced an error in one of its trials for its main treatment. Acelyrin, which is a part of Westlake Village BioPartners investing portfolio, disclosed there was a programming error in a drug trial of izokibep, a treatment for psoriatic Read More →
